Brian Frezza & Emerald Therapeutics
Co-CEO and Co-founder, Emerald Therapeutics
Areas: Biotechnology
Brian Frezza, Co-CEO and Co-founder of Emerald Therapeutics, has integrated Mathematica at many organizational levels within the company—from using it as a standard documentation tool for the Emerald Therapeutics computer platform to controlling laboratory robots. Although the business is small, Mathematica has been broadly integrated in a manner rarely seen, even by Mathematica’s power users. Emerald’s small team has used Mathematica to conduct more than half a million biotech experiments.